BTLA and B-cell chronic lymphocytic leukemia: Given that aberrant BTLA expression in CLL has been demonstrated, as we previously reported in the B cell population [25,33], we aimed to verify whether BTLA molecule expression and its eventual modification at the epigenetic level might affect T cell effector functions.